IndiaOne Finance - Company Dashboard

Governance Classic Home

AstraZeneca Pharma India LtdPharmaceuticalsINE203A01020Standalone₹6650.00-101.50 (-1.50%)Jun-26

Valuation

Market Cap₹16.63K Cr

TTM PE98.01x

Forward PE108.05x

PEG-10.26

Book Value₹349.12

P/B19.05x

TTM EPS₹67.85

Fwd EPS₹61.55

TTM Revenue₹2.43K Cr

TTM PAT₹169.62 Cr

TTM EBITDA₹229.86 Cr

TTM EBIT₹212.62 Cr

Last Qtr PAT₹37.93 Cr

Last Qtr EBITDA₹48.94 Cr

Last Qtr EBIT₹43.71 Cr

Profitability

ROE19.43%

ROCE24.00%

TTM NPM6.97%

TTM EBITDA %9.45%

Curr OPM5.48%

Last OPM7.68%

Curr NPM—

Last NPM—

Curr EPS₹15.17

Last EPS₹17.95

Balance sheet

Equity₹5.00 Cr

Reserve₹867.79 Cr

Total Debt₹110.66 Cr

D/E0.13x

Interest %5.14%

Curr Interest₹1.95 Cr

Price / range

Close₹6650.00

vs 52W High-32.49%

vs 52W Low+0.76%

MA50—

MA200—

Returns

1D-1.50%

1W-1.69%

1M-10.32%

3M-21.15%

6M-19.92%

1Y-25.60%

2Y-3.09%

3Y+47.43%

5Y+114.63%

Diwali-24.24%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1868.90	₹4.48L Cr	150.72	3.58%
DIVISLAB	9410.50	₹2.50L Cr	84.94	17.55%
TORNTPHARM	4970.00	₹1.89L Cr	80.92	25.43%
ZYDUSLIFE	1161.00	₹1.16L Cr	33.24	12.96%
CIPLA	1386.10	₹1.12L Cr	36.42	8.93%
LAURUSLABS	2017.50	₹1.09L Cr	124.85	16.46%
MANKIND	2437.80	₹1.01L Cr	46.14	13.38%
DRREDDY	1198.30	₹1.00L Cr	150.35	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	682.79+29.7%	578.61	611.57	559.09	526.31	2,275.58
Other Income	9.23	5.95	5.13	6.17	11.24	28.49
Total Income	692.02+28.7%	584.56	616.70	565.26	537.55	2,304.07
Interest	1.95	2.04	1.06	0.67	0.72	4.49
Expenditure	-641.03-38.6%	-525.34	-571.64	-487.15	-462.49	-2,046.62
PBDT	0	0	0	0	0	0
EBITDA	48.94-39.7%	60.91	44.83	75.18	81.11	262.03
Depreciation	-5.23	-5.60	-3.84	-2.57	-16.57	-28.58
EBIT	43.71-32.3%	55.31	40.99	72.61	64.54	233.45
PBT	50.75-32.1%	58.14	46.54	72.82	74.70	252.20
Tax	-12.82	-13.26	-13.95	-18.60	-18.87	-64.68
Equity	5	5	5	0	5	5
OPM	7.33	9.95	7.55	13.02	13.90	10.95
Net Profit	37.93-32.1%	44.88	32.59	54.22	55.83	187.52
NPM	5.48	7.68	5.28	9.70	10.39	8.14
EPS	15.17-32.1%	17.95	13.04	21.69	22.33	75.01

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	2,275.58+32.6%	1,716.29+32.5%	1,295.53+29.2%	1,002.97+24.5%	805.60-1.0%	813.56
Other Income	28.49	40.63	34.80	26.10	14.76	12.84
Total Income	2,304.07+31.1%	1,756.92+32.1%	1,330.33+29.3%	1,029.07+25.4%	820.36-0.7%	826.41
Expenditure	-2,046.62-36.1%	-1,503.77-33.4%	-1,127.22-31.9%	-854.74-15.9%	-737.32-5.4%	-699.31
Interest	-4.49	-1.46	-1.20	-0.63	-0.95	0
PBDT	0	0	0	0	0	0
EBITDA	262.03+3.2%	253.97+37.7%	184.45+11.7%	165.12+91.6%	86.18-24.6%	114.25
Depreciation	-28.58	-39.99	-14.94	-16.26	-16.95	0
EBIT	233.45+9.1%	213.98+26.2%	169.51+13.9%	148.86+115.0%	69.23-39.4%	114.25
PBT	252.20+61.3%	156.36-28.8%	219.54+63.7%	134.11+61.5%	83.04-34.7%	127.09
Tax	-64.68	-40.62	-58.03	-34.81	-21.44	-33.79
Equity	5	5	0	0	0	0
OPM (%)	10.95	8.90	17.00	13.00	10.00	15.00
Net Profit	187.52+62.0%	115.74-28.3%	161.51+62.7%	99.29+61.2%	61.59-34.0%	93.30
NPM (%)	8.14	6.59	12.00	10.00	8.00	11.00
EPS (Rs)	75.01+62.0%	46.30-28.3%	64.60+62.6%	39.72+61.2%	24.64-34.0%	37.32
CEPS	0	46.30	64.60	39.72	24.64	37.32

Metric	FY25-26
Revenue	2,275.58
Other Income	28.49
Total Income	2,304.07
Interest	4.49
Expenditure	-2,046.62
PBDT	0
EBITDA	262.03
Depreciation	-28.58
EBIT	233.45
PBT	252.20
Tax	-64.68
Equity	5
OPM	10.95
Net Profit	187.52
NPM	8.14
EPS	75.01

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25
Revenue	2,275.58+32.6%	1,716.29
Other Income	28.49	40.63
Total Income	2,304.07+31.1%	1,756.92
Expenditure	-2,046.62-36.1%	-1,503.77
Interest	-4.49	-1.46
PBDT	0	0
EBITDA	262.03+3.2%	253.97
Depreciation	-28.58	-39.99
EBIT	233.45+9.1%	213.98
PBT	252.20+61.3%	156.36
Tax	-64.68	-40.62
Equity	5	5
OPM (%)	10.95	8.90
Net Profit	187.52+62.0%	115.74
NPM (%)	8.14	6.59
EPS (Rs)	75.01+62.0%	46.30
CEPS	0	46.30

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	36	31 Jul 2026
2025	Final Dividend	32	18 Jul 2025
2024	Final Dividend	24	05 Jul 2024
2023	Final Dividend	16	14 Jul 2023
2022	Final Dividend	8	07 Jul 2022
2022	Interim Dividend	2	18 Aug 2021
2021	Interim Dividend	2	20 Aug 2020
2020	Interim Dividend	1	20 Aug 2019
2012	Final Dividend	3.5	09 Jul 2012
2011	Final Dividend	10	07 Jul 2011
2010	Final Dividend	10	06 May 2010
2009	Final Dividend	15	29 Apr 2009
2008	Final Dividend	15	11 Apr 2008

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split